Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Kairos Pharma, LTD. has filed 116 SEC EDGAR filings since 29 Mar 2023

SEC filing history

Showing 1-25 of 116 matching filings.

Per page
25
Current page
1
DEFA14A File 001-42275

DEFA14A

Filing date
26 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-42275

ARS

Filing date
22 May 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-42275

DEF 14A

Filing date
22 May 2026
Reporting date
22 May 2026
Next action
Verify source filing
PRE 14A File 001-42275

PRE 14A

Filing date
11 May 2026
Reporting date
11 May 2026
Next action
Verify source filing
424B3 File 333-284569

424B3

Filing date
01 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-286662

424B3

Filing date
01 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-292686

EFFECT filing

Filing date
23 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-292686

UPLOAD filing

Filing date
15 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Dec 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Dec 2025
Reporting date
16 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
16 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .